Form D · Biotechnology
REATA PHARMACEUTICALS INC
Plano, TX · CIK 0001358762
Offering snapshot reported Jun 25, 2020 · SEC filing
- Reported sold
- $50M Offering amount: $50M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 24, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 25, 2020 | Initial | $50,000,000 | No comparison | 2 | SEC filing |
| Jul 13, 2011 | Initial | $300,000,000 | No comparison | 1 | SEC filing |
| Oct 5, 2010 | Initial | $16,977,840 | No comparison | 30 | SEC filing |
| Feb 26, 2010 | Initial | $1,972,000 | No comparison | 1 | SEC filing |
| Sep 28, 2009 | Initial | $16,977,840 | No comparison | 30 | SEC filing |
| Dec 10, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jun 26, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jul 3, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Mar 27, 2006 | Paper | Not reported | No comparison | Not reported |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-369735
Source: Form D, filed Jun 25, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Paul Audhya | Executive |
| James E. Bass | Director |
| Dawn C. Bir | Executive |
| Casi De Young | Executive |
| Catherine Fanning | Executive |
| Eric Grossman | Executive |
| J. Warren Huff | Director, Executive |
| Robert M. Kral, Jr. | Executive |
| Melissa Krauth | Executive |
| William D. Mc C Lellan, Jr. | Director |
| Kent Mc Gaughy | Director |
| J. Kent Mc Gaughy, Jr. | Director |
| Colin Meyer | Executive |
| Colin J. Meyer, M.D. | Executive |
| Jack B. Nielsen | Director |
| Edward W. Rose | Director |
| William E. Rose | Director |
| Charles A. Sanders | Director |
| Manmeet S. Soni | Executive |
| Dennis Stone | Director |
| Melean Visnick | Executive |
| John Walling | Executive |
| William Christian Wigley | Executive |
| Jason D. Wilson | Executive |
| Michael D. Wortley | Executive |
| Nancy Wysenski | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
5320 Legacy Drive
Plano, TX, 75024
Plano, TX, 75024